For research use only. Not for therapeutic Use.
Revdofilimab（Cat No.:I041522）is an investigational monoclonal antibody being studied for its potential use in cancer immunotherapy. It targets the PD-1 (programmed cell death protein 1) receptor on T cells, a checkpoint inhibitor that suppresses immune responses against tumors. By blocking PD-1, revdofilimab aims to enhance the immune system’s ability to recognize and attack cancer cells. It is being evaluated in clinical trials for various cancers, including non-small cell lung cancer and melanoma. Revdofilimab is part of the expanding field of immuno-oncology therapies that focus on checkpoint inhibition to fight cancer.
| Catalog Number | I041522 |
| CAS Number | 2230138-89-1 |
| Purity | ≥95% |
